rs137886900

Variant summary

Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong

The NM_004614.5(TK2):​c.547C>T​(p.Arg183Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000781 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R183Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000077 ( 0 hom. )

Consequence

TK2
NM_004614.5 missense

Scores

15
1
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7O:1

Conservation

PhyloP100: 5.18

Publications

19 publications found
Variant links:
Genes affected
TK2 (HGNC:11831): (thymidine kinase 2) This gene encodes a deoxyribonucleoside kinase that specifically phosphorylates thymidine, deoxycytidine, and deoxyuridine. The encoded enzyme localizes to the mitochondria and is required for mitochondrial DNA synthesis. Mutations in this gene are associated with a myopathic form of mitochondrial DNA depletion syndrome. Alternate splicing results in multiple transcript variants encoding distinct isoforms, some of which lack transit peptide, so are not localized to mitochondria. [provided by RefSeq, Dec 2012]
TK2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome, myopathic form
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive progressive external ophthalmoplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 15 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_004614.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-66517207-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 38991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.827
PP5
Variant 16-66517207-G-A is Pathogenic according to our data. Variant chr16-66517207-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 38992.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004614.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TK2
NM_004614.5
MANE Select
c.547C>Tp.Arg183Trp
missense
Exon 8 of 10NP_004605.4
TK2
NM_001172645.2
c.493C>Tp.Arg165Trp
missense
Exon 7 of 9NP_001166116.1
TK2
NM_001172644.2
c.472C>Tp.Arg158Trp
missense
Exon 7 of 9NP_001166115.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TK2
ENST00000544898.6
TSL:1 MANE Select
c.547C>Tp.Arg183Trp
missense
Exon 8 of 10ENSP00000440898.2
TK2
ENST00000451102.7
TSL:1
c.454C>Tp.Arg152Trp
missense
Exon 8 of 10ENSP00000414334.4
TK2
ENST00000527284.6
TSL:1
c.490C>Tp.Arg164Trp
missense
Exon 8 of 9ENSP00000435312.2

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152128
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000107
AC:
27
AN:
251488
AF XY:
0.0000956
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.0000527
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000766
AC:
112
AN:
1461794
Hom.:
0
Cov.:
31
AF XY:
0.0000811
AC XY:
59
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000842
AC:
45
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000504
AC:
56
AN:
1111920
Other (OTH)
AF:
0.0000993
AC:
6
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152128
Hom.:
0
Cov.:
32
AF XY:
0.000135
AC XY:
10
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41434
American (AMR)
AF:
0.00
AC:
0
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000661
AC:
7
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68030
Other (OTH)
AF:
0.000956
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000959
Hom.:
0
Bravo
AF:
0.0000378
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial DNA depletion syndrome, myopathic form Pathogenic:2Other:1
Sep 01, 2017
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been previously reported as disease-causing and was found once in our laboratory in trans with another pathogenic variant (H121N) in a 16-year-old female with proximal muscle weakness. Heterozygotes are expected to be asymptomatic carriers.

GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Apr 04, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Pathogenic:2
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 183 of the TK2 protein (p.Arg183Trp). This variant is present in population databases (rs137886900, gnomAD 0.08%). This missense change has been observed in individuals with mitochondrial DNA depletion syndrome (PMID: 15907288, 18819985, 29602790). It has also been observed to segregate with disease in related individuals. This variant is also known as c.673C>T, p.R225W. ClinVar contains an entry for this variant (Variation ID: 38992). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TK2 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TK2 function (PMID: 21937588). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Arg183 amino acid residue in TK2. Other variant(s) that disrupt this residue have been observed in individuals with TK2-related conditions (PMID: 12655576, 12682338, 19265691), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

Jan 29, 2022
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 Pathogenic:1
Jan 01, 2012
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Mitochondrial disease Pathogenic:1
Apr 10, 2025
Genomenon, Inc, Genomenon, Inc
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

TK2 Arg183Trp (c.547C>T) is a missense variant that changes the amino acid at residue 183 from Arginine to Tryptophan. It is also described as R225W in the literature. This variant has been observed in multiple probands affected with mitochondrial disease in both the homozygous and compound heterozygous state, with a pathogenic or likely pathogenic variant confirmed in trans in several of these probands (PMID:33013660;18819985;15907288;23932787;21937588). TK2 Arg183Trp was found to segregate with disease in affected families (PMID:15907288;21937588). Experimental studies have shown that this variant results in a significant reduction of catalytic activity compared to the wild type (PMID:21937588). This variant is not present at a significant frequency in gnomAD, and in silico models agree that this variant is possibly or probably damaging. In conclusion, we classify TK2 Arg183Trp (c.547C>T) as a pathogenic variant.

Mitochondrial DNA depletion syndrome Pathogenic:1
Apr 13, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: TK2 c.547C>T (p.Arg183Trp) results in a non-conservative amino acid change located in the Deoxynucleoside kinase domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 251488 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TK2 causing Mitochondrial DNA Depletion Syndrome - TK2 Related (0.00011 vs 0.0011), allowing no conclusion about variant significance. c.547C>T has been reported in the literature in individuals affected with Mitochondrial DNA Depletion Syndrome - TK2 Related. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.47
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.97
D
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.45
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.0
M
PhyloP100
5.2
PrimateAI
Benign
0.32
T
PROVEAN
Pathogenic
-5.9
D
REVEL
Pathogenic
0.92
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.82
MutPred
0.73
Gain of catalytic residue at P228 (P = 0.0456)
MVP
1.0
MPC
1.1
ClinPred
0.88
D
GERP RS
5.6
Varity_R
0.84
gMVP
0.62
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137886900; hg19: chr16-66551110; COSMIC: COSV55284582; COSMIC: COSV55284582; API